Terms: = Colorectal cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
27 results:
1. The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.
Carberry S; D'Orsi B; Monsefi N; Salvucci M; Bacon O; Fay J; Rehm M; McNamara D; Kay EW; Prehn JHM
Cell Death Dis; 2018 Jan; 9(2):125. PubMed ID: 29374142
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of multiple proteins with clinic-pathological features and its prognostic significance in colorectal cancer with signet-ring cell component.
Cai X; Qi WX; Wang L; Zhang Z
Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3358-67. PubMed ID: 27608893
[TBL] [Abstract] [Full Text] [Related]
3. BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.
Cremolini C; Di Bartolomeo M; Amatu A; Antoniotti C; Moretto R; Berenato R; Perrone F; Tamborini E; Aprile G; Lonardi S; Sartore-Bianchi A; Fontanini G; Milione M; Lauricella C; Siena S; Falcone A; de Braud F; Loupakis F; Pietrantonio F
Ann Oncol; 2015 Oct; 26(10):2092-7. PubMed ID: 26153495
[TBL] [Abstract] [Full Text] [Related]
4. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract] [Full Text] [Related]
5. A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Szkandera J; Pichler M; Absenger G; Stotz M; Weissmueller M; Samonigg H; Asslaber M; Lax S; Leitner G; Winder T; Renner W; Gerger A
Clin Cancer Res; 2014 Mar; 20(6):1687-97. PubMed ID: 24470513
[TBL] [Abstract] [Full Text] [Related]
6. Decrease of survivin, p53 and bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres.
Melucci E; Cosimelli M; Carpanese L; Pizzi G; Izzo F; Fiore F; Golfieri R; Giampalma E; Sperduti I; Ercolani C; Sciuto R; Mancini R; Garufi C; Diodoro MG; Mottolese M;
J Exp Clin Cancer Res; 2013 Mar; 32(1):13. PubMed ID: 23497522
[TBL] [Abstract] [Full Text] [Related]
7. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract] [Full Text] [Related]
8. Can the clinical outcome in stage II colon carcinomas be predicted by determination of molecular marker expression?
Fernández-Cebrián JM; Nevado Santos M; Vorwald Kuborn P; Pardo de Lama M; Martín-Cavanna J; Pacheco Martínez P; Fernández Escudero B; Ramos Fernández M
Clin Transl Oncol; 2007 Oct; 9(10):663-70. PubMed ID: 17974527
[TBL] [Abstract] [Full Text] [Related]
9. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y
J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966
[TBL] [Abstract] [Full Text] [Related]
10. Studies on p53, BAX and bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
Nehls O; Okech T; Hsieh CJ; Enzinger T; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Hass HG; Arkenau HT; Hartmann JT; Porschen R; Gregor M; Klump B
Br J Cancer; 2007 May; 96(9):1409-18. PubMed ID: 17426704
[TBL] [Abstract] [Full Text] [Related]
11. p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy.
Lin LC; Lee HH; Hwang WS; Li CF; Huang CT; Que J; Lin KL; Lin FC; Lu CL
Surg Oncol; 2006 Dec; 15(4):211-6. PubMed ID: 17360176
[TBL] [Abstract] [Full Text] [Related]
12. bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract] [Full Text] [Related]
13. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer.
Demirbaş S; Sücüllü I; Yildirim S; Celenk T
Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272
[TBL] [Abstract] [Full Text] [Related]
14. Bio-pathological factors of prognostic value in colorectal adenocarcinomas.
Mottolese M; Buglioli S; Piperno G; Sperduti I; Giannarelli D; D'Angelo C; Cosimelli M
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):163-6. PubMed ID: 16767924
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
Krajewska M; Kim H; Kim C; Kang H; Welsh K; Matsuzawa S; Tsukamoto M; Thomas RG; Assa-Munt N; Piao Z; Suzuki K; Perucho M; Krajewski S; Reed JC
Clin Cancer Res; 2005 Aug; 11(15):5451-61. PubMed ID: 16061861
[TBL] [Abstract] [Full Text] [Related]
16. Changes in Mcl-1 expression in rectal cancer in relation to neo-adjuvant radiotherapy.
Ulrich-Pur H; Erovic BM; Soleiman A; Jech B; Pennwieser W; Czembirek C; Zielinski CC; Thurnher D
Wien Klin Wochenschr; 2005 Feb; 117(4):136-40. PubMed ID: 15847193
[TBL] [Abstract] [Full Text] [Related]
17. Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma.
Bendardaf R; Ristamäki R; Kujari H; Laine J; Lamlum H; Collan Y; Pyrhönen S
Oncology; 2003; 64(4):435-42. PubMed ID: 12759543
[TBL] [Abstract] [Full Text] [Related]
18. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, bcl-2, MUC-1 AND p27(kip-1).
Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
[TBL] [Abstract] [Full Text] [Related]
19. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
[TBL] [Abstract] [Full Text] [Related]
20. Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer.
Backus HH; van Riel JM; van Groeningen CJ; Vos W; Dukers DF; Bloemena E; Wouters D; Pinedo HM; Peters GJ
Ann Oncol; 2001 Jun; 12(6):779-85. PubMed ID: 11484952
[TBL] [Abstract] [Full Text] [Related]
[Next]
